CG Oncology, Inc. (CGON)
(Delayed Data from NSDQ)
$30.02 USD
-2.41 (-7.43%)
Updated May 9, 2024 04:00 PM ET
After-Market: $30.02 0.00 (0.00%) 5:12 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Brokerage Reports
0 items in cart
CG Oncology, Inc. [CGON]
Reports for Purchase
Showing records 1 - 2 ( 2 total )
Company: CG Oncology, Inc.
Industry: Medical - Biomedical and Genetics
Cretostimogene Looks to Impress with 12-Month CR Data from Pivotal BOND-003 Study During AUA 24
Provider: H.C. Wainwright & Co., Inc.
Analyst: MALDONADO A
Company: CG Oncology, Inc.
Industry: Medical - Biomedical and Genetics
Cretostimogenes Regime Aims to Transform the NMIBC Scene; Initiating Coverage With a Buy Rating and $75 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: MALDONADO A
|